Back to Search
Start Over
Supplementary Figure 2 from Phase Ia Study of Anti-NaPi2b Antibody–Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non–Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Figure S2. Representative NaPi2b ICH images for PROC and NSCLC patients.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....3f4792574451e294405cc4ee7c39e46f
- Full Text :
- https://doi.org/10.1158/1078-0432.22474397